Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Undisclosed
Partner/Sponsor/Collaborator: Novo Seeds
Deal Size: $10.6 million Upfront Cash: Undisclosed
Deal Type: Series A Financing October 13, 2020
Rappta has developed proprietary tools and a unique understanding of PP2A which allows it to therapeutically reactivate PP2A.